Connect your AI

ICU Medical ICUI 2031

2031 at other companies

MedtronicMDT

——

SolventumSOLV

——

AbbottABT

——

Other financials

Income statement

Revenue$530.2M-12.3%

Gross profit$206.2M-1.8%

Operating income$13.6M+5.4%

Net income$30.1M+295%

EPS (diluted)$1.20+290%

Balance sheet

Cash & equivalents$288.3M-0.5%

Total debt$1.4B-17.5%

Total equity$2.1B+6.3%

Total assets$4.0B-4.1%

Cash flow

Operating cash flow$38.9M-24.2%

CapEx$11.3M-22.7%

Free cash flow$27.6M-24.8%

Valuation

Market cap$3.39B-6.3%

Profitability

Gross margin37.9%+2.8pp

Operating margin2%-0.7pp

Net margin-0.3%-0.2pp

FCF margin4.2%-1.2pp

Returns & leverage

Return on equity-0.4%-0.2pp

Debt / equity0.6×-0.2×

Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's 2031.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ICU Medical's 2031?: ICU Medical (ICUI) reported 2031 of $64.06M in Q1 2026.
How has ICU Medical's 2031 changed year-over-year?: ICU Medical's 2031 increased by 21.8% year-over-year, from $52.62M to $64.06M.